CD154 Blockade Alters Innate Immune Cell Recruitment and Programs Alloreactive CD8(+) T Cells into KLRG-1(high) Short-Lived Effector T Cells

CD154/CD40 blockade combined with donor specific transfusion remains one of the most effective therapies in prolonging allograft survival. Despite this, the mechanisms by which these pathways synergize to prevent rejection are not completely understood. Utilizing a BALB/c (H2-K(d)) to B6 (H2-K(b)) f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrer, Ivana R., Wagener, Maylene E., Song, Mingqing, Ford, Mandy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390379/
https://www.ncbi.nlm.nih.gov/pubmed/22792369
http://dx.doi.org/10.1371/journal.pone.0040559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390379/
https://www.ncbi.nlm.nih.gov/pubmed/22792369
http://dx.doi.org/10.1371/journal.pone.0040559

Ejemplares similares